Get started
Author

Chengpei Zhu

Long Noncoding RNA Plays a Key Role in Metastasis and Prognosis of Hepatocellular Carcinoma
2014 · Guangbing Li, Haohai Zhang, et al. · BioMed Research International · 115
PDF
Coffee and cancer risk: A meta-analysis of prospective observational studies
2016 · Anqiang Wang, Shanshan Wang, et al. · Scientific Reports · 85
PDF
Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma
2015 · Haohai Zhang, Chengpei Zhu, et al. · Oncotarget · 71
PDF
Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma
2024 · Chengpei Zhu, Chenchen Zhang, et al. · Journal for ImmunoTherapy of Cancer · 58
Mst1 regulates colorectal cancer stress response via inhibiting Bnip3-related mitophagy by activation of JNK/p53 pathway
2017 · Qi Li, Feng Qi, et al. · Cell Biology and Toxicology · 56
Fabp3 Inhibits Proliferation and Promotes Apoptosis of Embryonic Myocardial Cells
2011 · C. Zhu, D. L. Hu, et al. · Cell Biochemistry and Biophysics · 44
PDF
Radiation Therapy With Combination Therapy of Immune Checkpoint Inhibitors and Antiangiogenic Therapy for Hepatocellular Carcinoma
2023 · Cong Ning, Xinmu Zhang, et al. · International Journal of Radiation Oncology*Biology*Physics · 40
PDF
Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer
2023 · Chengpei Zhu, Jingnan Xue, et al. · Frontiers in Immunology · 40
PDF
Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer
2024 · Chengpei Zhu, Yunchao Wang, et al. · Biomarker Research · 38
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study
2023 · Chengpei Zhu, Hu Li, et al. · Cancer Immunology Immunotherapy · 34
PDF
Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma
2023 · Yan-Yu Wang, Xu Yang, et al. · World Journal of Gastroenterology · 31
PDF
Application of plasma circulating cell-free DNA detection to the molecular diagnosis of hepatocellular carcinoma.
2019 · Gaixia He, Yanhui Chen, et al. · PubMed · 27
Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis
2023 · Jiashuo Chao, Shanshan Wang, et al. · Cancer Immunology Immunotherapy · 26
PDF
Research progress and prospects of markers for liver cancer stem cells
2015 · Cheng-Pei Zhu · World Journal of Gastroenterology · 26
PDF
Conversion surgery intervention versus continued systemic therapy in patients with a response after PD-1/PD-L1 inhibitor-based combination therapy for initially unresectable biliary tract cancer: a retrospective cohort study
2024 · Shanshan Wang, Yunchao Wang, et al. · International Journal of Surgery · 24
Citrus Fruit Intake Substantially Reduces the Risk of Esophageal Cancer
2015 · Anqiang Wang, Chengpei Zhu, et al. · Medicine · 23
Identification of the molecular relationship between intravenous leiomyomatosis and uterine myoma using RNA sequencing
2019 · Xu Zhang, Liangcai Wu, et al. · Scientific Reports · 20
PDF
The fusion landscape of hepatocellular carcinoma
2019 · Chengpei Zhu, Liangcai Wu, et al. · Molecular Oncology · 19
PDF
Dr.VIS v2.0: an updated database of human disease-related viral integration sites in the era of high-throughput deep sequencing
2014 · Xiaobo Yang, Ming Li, et al. · Nucleic Acids Research · 19
PDF
Clinicopathological Features of Gallbladder Papillary Adenocarcinoma
2014 · Xueshuai Wan, Haohai Zhang, et al. · Medicine · 18
Comparison of harmonic scalpel and conventional technique in the surgery for breast cancer: A systematic review and meta-analysis
2018 · Xiangchao Meng, Zili Zhang, et al. · Indian Journal of Cancer · 17
Gallbladder papillary neoplasms share pathological features with intraductal papillary neoplasm of the bile duct
2017 · Xueshuai Wan, Jie Shi, et al. · Oncotarget · 14
PDF
Lenvatinib combined with PD-1 inhibitor plus Gemox chemotherapy versus plus HAIC for advanced biliary tract cancer
2024 · Ting Zhang, Chengpei Zhu, et al. · International Immunopharmacology · 13
Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC
2023 · Yunchao Wang, Nan Zhang, et al. · Frontiers in Immunology · 12
PDF
A new avenue for obtaining insight into the functional characteristics of long noncoding RNAs associated with estrogen receptor signaling
2016 · Liangcai Wu, Qianqian Xu, et al. · Scientific Reports · 12
PDF
Works count: 51
Citation count: 942
H-index: 19
I10-index: 25
Year
Topic
Type